Fluorouracil and dose-dense adjuvant chemotherapy in patients with early-stage breast cancer (GIM2): end-of-study results from a randomised, phase 3 trialLucia Del Mastro, A Parisi, Mario Giuliano et al.|The Lancet Oncology|2022Cited by 50
Efficacy of adjuvant chemotherapy schedules for breast cancer according to body mass index: results from the phase III GIM2 trialFrancesca Poggio, Lucia Del Mastro, Eva Blondeaux et al.|ESMO Open|2024Cited by 5